Bluejay Diagnostics, Inc. (NASDAQ: BJDX) reported Q3 EPS of ($2.08), $2.00 worse than the analyst estimate of ($0.08).

For earnings history and earnings-related data on Bluejay Diagnostics, Inc. (BJDX) click here.